Cargando…
Clinical and Epidemiological Characteristics of Coronavirus Disease 2019 in Iran: a Hospital-Based Observational Study
BACKGROUND: Coronavirus disease 2019 (COVID-19) has been pandemic and has caused a great burden on almost all countries across the world. Different perspectives of this novel disease are poorly understood. This study sought to investigate the clinical and epidemiological characteristics of COVID-19...
Autores principales: | Darazam, Ilad Alavi, Besharati, Sajad, Shabani, Minoosh, Shokouhi, Shervin, Fallahzadeh, Mohammad, Shabanpour Dehbsneh, Hadiseh, Khalili, Negar, Soleymaninia, Azam, Hoseyni Kusha, Akram, Taleb Shoushtari, Maryam, Amirdosara, Mahdi, Hajiesmaeili, Mohammadreza, Rezaei, Omidvar, Khoshkar, Ali, Naghibi Irvani, Seyed Sina, Kheyrian, Mahnaz, Goudarzi, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710226/ https://www.ncbi.nlm.nih.gov/pubmed/34976087 |
Ejemplares similares
-
Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2021) -
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2021) -
Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19
por: Shabani, Minoosh, et al.
Publicado: (2021) -
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2020) -
Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial
por: Sahraei, Zahra, et al.
Publicado: (2022)